New Phase 1 Trial Results Capture Big But Misleading Headlines
November 29, 2015
A Phase I study has resulted in some very hopeful headlines about a possible cure. Unfortunately, the headlines are far more promising and hopeful than the actual facts. Click here to read more.
November 6, 2015
This report will provide an overview of the TypeOneNation Summit regarding both technological advances and research. Click here to read more.
November 3, 2015
The board of directors at JDRF and the ADA ultimately have more influence over spending and strategy than anyone else at the organization. Board members set the organization’s strategic direction and have the final say in funding allocations. Click here to read more.
JDRF/JDCA Breakfast Meeting Flash Report
October 26, 2015
Last Friday, the JDCA accepted an invitation to a breakfast meeting in New York with JDRF CEO, Derek Rapp, and John Brady, Chairman of the JDRF International Board, to discuss current and future JDRF priorities. Click here to read more.
Analyzing the ADA's Annual Income Utilization
October 15, 2015
This is the third annual analysis of the ADA's funding for research to help ensure that the priorities of the T1D community are not lost in the ADA's heavy focus on type 2 diabetes. Click here to read more.
Joslin's New Ceo Announced
October 5, 2015
Starting on October 5th, Dr. Peter Amenta will become the new Joslin President and CEO. Click here to read more.
Analyzing the JDRF's annual income utilization
September 22, 2015
This is the third annual analysis of JDRF's research funding. The main purpose in reviewing and sharing this data is to help ensure that T1D donor and community priorities are being addressed. Click here to read more.
The Bionic Pancreas: Further along FDA Testing Than Any Other AP
July 30, 2015
Among the the many artificial pancreas (AP) designs under development, the Bionic Pancreas project led by Dr. Ed Damiano of Boston University is progressing rapidly through human trials. Last week the JDCA had the opportunity to meet face-to-face with Dr. Damiano. Click here to read more.
Islet Transplantation: A Brief Overview
July 14, 2015
This report provides a basic overview of the status of islet transplantation, one of the four Practical Cure pathways. The JDCA will publish an overview of each of the other three Practical Cure pathways over the coming months. Click here to read more.
Update on Emerging Practical Cure Projects
June 24, 2015
A few weeks ago the JDCA published a report identifying research projects in human trials that may result in a Practical Cure. We also track Practical Cure projects which may begin human trials in the next 24 months. This report provides a list of those projects. Click here to read more.
Updates on Practical Cure Projects In Human Clinical Trials
June 10, 2016
This is the semi-annual review of T1D research in human clinical trials. The review identified 361 open trials that focus on T1D and only 11 initiatives have the potential to deliver a Practical Cure. Click here to read more.
Four Potential Research Pathways to a Practical Cure
May 28, 2015
This report is the first in a series of updates on developments in Practical Cure research platforms and projects. It outlines the four research pathways that we believe have the potential to deliver a Practical Cure within the next 15 years. Click here to read more.
Edmonton Protocol Leader Publishes New Research that May Improve Islet Transplantation
May 7, 2015
The Journal of Nature Biology recently published results that appear to be a small step forward in islet transplantation. Click here to read more.
New Clinical Trial Repurposes Rheumatoid Arthritus Drug for T1D
April 16, 2015
Last week, Bloomberg News reported on a Phase II clinical trial that is testing whether an FDA-approved rheumatoid arthritis drug can be re-purposed to delay or halt the onset of type 1 diabetes. Click here to read more.
JDRF Cost of Administering Research Grants Doubles in 5 Years
April 1, 2015
JDRF is becoming less efficient at administering research grants. In 2014, it cost JDRF $.22 to administer each grant dollar of research, the highest level of any year in the past decade. Click here to read more.
New Study: T1D Treatments a 7 Billion Rapidly Growing Global Business
March 26, 2015
A new study released by GlobalData, a London-based market research and analytics firm, estimates that the global market for type 1 diabetes treatments will double in the next decade, from $6.6 Billion in 2013 to $13.6 Billion by 2023. Click here to read more.
Semma Therapeutics Raises $44 Million to Commercialize T1D Stem-Cell Research from Doug Melton’s Harvard Lab
March 25, 2015
Today, the Boston Globe announced that a new company has been founded to commercialize T1D research out of Dr. Doug Melton’s laboratory at Harvard University. Click here to read more.